Merck & Co Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg, a) 30 count blister recall — FDA D-1310-2014
This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness…